Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009

JAMA Oncology - Tập 1 Số 8 - Trang 1098 - 2015
Michaela A. Dinan1,2,3, Xiaojuan Mi4, Shelby D. Reed1,2,3, Gary H. Lyman5,6, Lesley H. Curtis1,7
1Department of Medicine, Duke University School of Medicine, Durham, North Carolina
2Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina
3Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina2Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Caroli
4Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina
5Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle
6Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle5Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle
7Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina3Department of Medicine, Duke University School of Medicine, Durham, North Carolina

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA Oncology

Tập 1 Số 8

1098

Thông tin tác giả